US Contrast Media Injectors Market
No. of Pages: 89 | Report Code: TIPRE00003911 | Category: Life Sciences
No. of Pages: 89 | Report Code: TIPRE00003911 | Category: Life Sciences
The US contrast media injectors market is expected to reach US$ 350.4 Mn in 2027 from US$ 183.8 Mn in 2018. The market is estimated to grow with a CAGR of 7.5% from 2019-2027.
The growth of the market is driven by the factors such as increasing number of approvals for contrast agents and increasing number of patients suffering with chronic diseases. However, the market is likely to get affected due to side effects associated with the contrast media agents during the forecast period.
In an aging society where chronic diseases is a leading factor in the health system, technical advancements are necessary to preserve the quality of life through keeping the affordable prices. Chronic diseases can be defined as medical conditions that lasts for one year or more and requires ongoing medical attention or limit activities of daily living. Chronic diseases such as cancer, heart diseases, musculoskeletal diseases, and others are the leading causes of death and disability that requires several imaging modalities for diagnostic and treatment monitoring purposes. According to the National Center for Chronic Disease Prevention and Health Promotion, chronic diseases takes up US$3.3 trillion in annual health care costs.
Additionally, there presence of robust products in the pipeline have been witnessed in the contrast media injectors market. For instance, Lantheus Medical Imaging, Inc., a US based medical imaging company actively involved in the commercialization of contrast media injectors and agents is undergoing clinical trials to develop Flurpiridaz F 18, a novel PET agent, with the first of two Phase 3 trials complete. Moreover, the company has also collaborated with academic centers in the U.S., Canada and the Europe to investigate fluorine-18-based positron emission tomography (PET) radiopharmaceutical imaging agent designed for molecular imaging of the norepinephrine pathway.
The US contrast media injectors market is segmented based on product and application. Among the product segment, the consumables segment is expected to grow at a significant rate of 7.7% during the forecast period. In addition, the segment is also anticipated to dominate the market by products during the year 2027, with a market share of around 65.0%
Strategic insights for the US Contrast Media Injectors provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 183.8 Million |
| Market Size by 2027 | US$ 350.4 Million |
| Global CAGR (2019 - 2027) | 7.5% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | United States
|
| Market leaders and key company profiles |
The geographic scope of the US Contrast Media Injectors refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The List of Companies
The US Contrast Media Injectors Market is valued at US$ 183.8 Million in 2018, it is projected to reach US$ 350.4 Million by 2027.
As per our report US Contrast Media Injectors Market, the market size is valued at US$ 183.8 Million in 2018, projecting it to reach US$ 350.4 Million by 2027. This translates to a CAGR of approximately 7.5% during the forecast period.
The US Contrast Media Injectors Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the US Contrast Media Injectors Market report:
The US Contrast Media Injectors Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The US Contrast Media Injectors Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the US Contrast Media Injectors Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For US Contrast Media Injectors Market
